Press Releases

February 8, 2012

Bristol-Myers Squibb to Present at Leerink Swann 2012 Global Healthcare Conference

TargetCancer Announces New Grants

Research and Markets: European Pharmaceutical and Biotech Contract Manufacturing Markets

CoLucid Founder Passes Away

Physical activity yields feelings of excitement, enthusiasm

Triglyceride Levels Predict Stroke Risk in Postmenopausal Women

Study shows an investigational urine test can predict high-risk prostate cancer in men who choose 'watchful waiting'

Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase III Results with the Investigational Antipsychotic

Illumina's Board Unanimously Rejects Roche's Unsolicited Tender Offer as Inadequate

Neuralstem President and CEO to Present at BIO CEO & Investor Conference 2012

Resverlogix to Present at The 14th Annual BIO CEO & Investor Conference

AstraZeneca US Broadens Income Eligibility for Prescription Savings Programs

Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study

Longitude Capital Expands Investment Team With Senior Hire

Omeros to Present at the 14th Annual BIO CEO & Investor Conference

FDA grants Roche's pertuzumab Priority Review for previously untreated HER2-positive metastatic breast cancer

GeneNews Enters Into MOU With Shanghai Biochip to Establish First Sentinel Centre for Personalized Medicine

Bend Research Signs License Agreement With Eli Lilly and Company

KYTHERA Biopharmaceuticals to Present at Leerink Swann 2012 Global Healthcare Conference

Trovagene Closes Acquisition of CLIA Laboratory Assets

caprotec bioanalytics Announces Further Patent Protection of its CCMS Technology

MarketsandMarkets: Global Biomarkers Market worth $25.79 Billion by 2016

Proxy Life Sciences Holding to Test Virtual-Biopsy Technology for Clinical Applications in Cancer, Cardiovascular, Neurological

Crossbeta Biosciences, Good Biomarker Sciences and U-Protein Express join forces to develop Alzheimer's disease biomarker

Horizon and UK NEQAS ICC Announce Partnership to Improve Accuracy of Lung Cancer Diagnostic Testing

Miraculins' PreVu Test Cleared for Sale by Health Canada

American Stroke Association Meeting Report

Study shows an investigational urine test can predict high-risk prostate cancer in men who choose 'watchful waiting'

Pepscan Therapeutics Achieves Milestones in Research Collaboration With Janssen R&D Ireland

Jürgen Frisch Appointed Chief Medical Officer of European Operations at Clinipace Worldwide

Paid Research Reports

More Research Reports >>